Navigation Links
CVS Caremark Ready to Support Patients and Payors Through Coming Era of Health Care Expansion
Date:10/8/2010

NEW YORK, Oct. 8 /PRNewswire-FirstCall/ -- CVS Caremark (NYSE: CVS) is leading the private-sector effort to address health care cost and quality issues, with several recently introduced initiatives now set to deliver long-term value, Chairman and CEO Tom Ryan, President and Chief Operating Officer Larry Merlo and other senior executives will report at the company's 2010 analyst meeting in New York City today.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO)

The company's recent investments in new approaches to advanced pharmacy care are at the heart of CVS Caremark's strategic plan to increase its leadership in and contributions to the areas of pharmacy services and health care, Ryan said.

The company estimates that the 32 million Americans who will be covered by the federal expansion of health coverage will generate upwards of 200 million prescriptions a year. This increase in demand for innovative pharmacy services will coincide with an increased demand overall for health care services, with 55 million Americans reaching or surpassing the age of 65 by 2015. At the same time, nearly $90 billion of branded drugs are scheduled to go off patent between 2010 and 2016, increasing CVS Caremark's opportunity to advance the use of generics, a key driver of both improved health outcomes and cost savings. With nearly $300 billion spent annually on health issues related to medication non-adherence, the company's approach to increasing adherence will further demonstrate the value of advanced pharmacy care.

In the area of primary care, CVS Caremark's MinuteClinic network of retail health clinics is projected to remain the far-and-away leader of its sector and the company also will describe its plans to expand MinuteClinic through 2015 to meet the expected increase in demand for pri
'/>"/>

SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
2. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
3. NCPA Commends Senate Aging Committee for Launching CVS Caremark Investigation to Examine Alleged Harm to Seniors, Medicare
4. CVS Caremark Announces 2010 Analyst Day
5. CVS Caremark Corporation Announces Quarterly Dividend
6. CVS Caremark Maintenance Choice Program Improves Medication Adherence for US Airways Employees and Dependents
7. CVS Caremark Presents Ongoing Behavioral Change Research Partnership Research to the Pittsburgh Business Group on Health
8. CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20
9. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
10. NCPA Statement on CVS Caremark-Aetna Agreement
11. CVS Caremark Corporation to Hold Conference Call to Discuss:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)...   MeridianRx earned highest possible score ... leading indicators during its recent URAC accreditation review ... very proud of earning this level of accreditation ... Operating Officer of MeridianRx. "It is a testament ... flexibility and innovation." URAC,s leading indicators ...
(Date:3/5/2015)... 2015 BioLineRx (NASDAQ: BLRX ... to identifying, in-licensing and developing promising therapeutic candidates, ... public offering of American Depositary Shares ("ADSs"), each ... of the ADSs in the offering are to ... Securities is acting as sole book-running manager for ...
(Date:3/5/2015)...  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... therapeutics including high value and difficult to manufacture ... full year 2014 financial results will be released ... opens for trading.  At 9:00 am Eastern Time, ... discuss the financial results and provide a business ...
Breaking Medicine Technology:MeridianRx Earns Highest URAC Accreditation Status 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2
... Company to Submit a Supplemental New Drug Application to ... Cephalon, Inc . (Nasdaq: CEPH ... clinical trial of NUVIGIL(R) (armodafinil) Tablets [C-IV] as a ... Based on these findings, Cephalon(R) will file a ...
... today announced that the Endocrinologic and Metabolic Drugs Advisory Committee ... finalized its discussions of questions related to liraglutide, a once-daily ... to the risk profile of liraglutide. , , ... A majority of Advisory Committee members supported that appropriate evidence ...
Cached Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is expected ... 2014 to 2019. , The global digital PCR (dPCR) and qPCR ... 2014 to 2019. Although the mature markets such as the U.S., ... (dPCR) and qPCR market the Asia-Pacific region is expected to grow ... growth of the digital PCR (dPCR) and qPCR market is driven ...
(Date:3/5/2015)... Shania Twain will be touring throughout ... She has hinted that this will be her final tour ... one last time. She has had a residency in Las ... has millions of loyal fans around the world. After opening ... and on June 30th she will be at Madison Square Garden ...
(Date:3/5/2015)... March 05, 2015 This week, ... in low-cost laminate flooring products, initiating widespread ... of eco-friendly building materials made primarily from bamboo, ... testing all their flooring products for volatile organic ... Benchmark International (BMH). Results from formaldehyde ...
(Date:3/5/2015)... March 05, 2015 A Bakersfield, Calif. state ... seven-week trial awarding the plaintiff Coleen M. Perry a ... result of a TVT-Abbrevo pelvic mesh sling device, manufactured by ... Tom Cartmell , a partner at Wagstaff & Cartmell ... for the plaintiff, along with Rich Freese and Tim Goss ...
(Date:3/5/2015)... March 05, 2015 AxoGen, Inc. ... on the peripheral nerve repair market, reported record revenue ... 31, 2014 compared to $2.98 million in the year-ago ... growth strategies. , “Our strong fourth quarter revenue ... nerve repair products which is driving increased surgeon adoption ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:With Homeowners Concerned About Formaldehyde, Cali Bamboo Puts Safety Above Bottom Line 2Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4
... worlds largest publisher of open access journals, is ... Magnetic Resonance (JCMR) is moving to BioMed Centrals ... publishers, Taylor & Francis. The move from a ... Society of Cardiovascular Magnetic Resonance (SCMR) members and ...
... OCALA, Fla., Dec. 12 Franck,s Compounding Lab ... Pharmacy Services in,Woodruff, Wisconsin. Island Pharmacy owners, Randy ... other personal interests. Selling their,pharmacy to Franck,s Compounding ... ensure the continuance of high quality prescriptions and ...
... up with community based, organizations and Babies "R" Us to help ... ... little ones, MERRILLVILLE, Ind., Dec. 12 With a traditional ... afternoon when,Anthem Blue Cross and Blue Shield hosts a community-wide baby ...
... fighting gum disease , , WEDNESDAY, Dec. 12 (HealthDay ... infections, and a weakened immune response may be to ... , In experiments with mice infected with the bacteria ... to battle gum infection than their normal-weight counterparts, according ...
... Austria, December 12 f-star, an antibody,engineering company ... unique Modular Antibody Technology, announced today that it,has ... three,outstanding scientists to form the nucleus of this ... Professor Sir Ravinder Maini, Imperial College, London, ...
... organizations in ... underserved areas, WOODLAND HILLS, Calif., Dec. 11 ... $30,000 in end of,year donations to various food banks throughout California. An ... and,southern California to assist vulnerable populations., Blue Cross employees will visit ...
Cached Medicine News:Health News:Society of Cardiovascular Magnetic Resonance chooses open access 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 2Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 3Health News:Obesity Weakens Immune Response 2Health News:Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board 2Health News:Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board 3Health News:Blue Cross of California Gives $30,000 in Holiday Donations to Food Banks Throughout the State 2
... Ziemer's FEMTO LDV, the first compact, mobile ... provide a versatile, powerful platform for a ... The basic system addresses the demand of ... that is consistent with an efficient LASIK ...
Stylish yet conservative, these classics are reliable, comfortable and durable....
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Inquire...
Medicine Products: